Kinneret Advisory LLC Purchases New Position in Metlife Inc (MET)

Kinneret Advisory LLC purchased a new position in shares of Metlife Inc (NYSE:MET) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 4,330 shares of the financial services provider’s stock, valued at approximately $178,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Vivaldi Capital Management LLC purchased a new position in shares of Metlife during the 4th quarter worth about $290,000. Brown Advisory Inc. lifted its holdings in shares of Metlife by 68.9% during the 4th quarter. Brown Advisory Inc. now owns 55,638 shares of the financial services provider’s stock worth $2,284,000 after acquiring an additional 22,698 shares during the period. Brown Advisory Securities LLC lifted its holdings in shares of Metlife by 77.2% during the 4th quarter. Brown Advisory Securities LLC now owns 74,002 shares of the financial services provider’s stock worth $3,085,000 after acquiring an additional 32,246 shares during the period. Stifel Financial Corp lifted its holdings in shares of Metlife by 7.7% during the 4th quarter. Stifel Financial Corp now owns 1,037,337 shares of the financial services provider’s stock worth $42,556,000 after acquiring an additional 73,812 shares during the period. Finally, Berman Capital Advisors LLC purchased a new position in shares of Metlife during the 4th quarter worth about $31,000. 74.09% of the stock is currently owned by institutional investors.

NYSE MET opened at $44.84 on Friday. Metlife Inc has a one year low of $37.76 and a one year high of $48.92. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.14 and a current ratio of 0.14. The company has a market capitalization of $42.92 billion, a P/E ratio of 8.32, a price-to-earnings-growth ratio of 0.96 and a beta of 1.20.

Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, February 6th. The financial services provider reported $1.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.05. Metlife had a net margin of 7.53% and a return on equity of 10.24%. The firm had revenue of $15.40 billion for the quarter, compared to analyst estimates of $15.84 billion. During the same quarter last year, the firm posted $0.64 earnings per share. Metlife’s revenue for the quarter was up .0% compared to the same quarter last year. Equities research analysts predict that Metlife Inc will post 5.48 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 13th. Investors of record on Tuesday, February 5th were issued a $0.42 dividend. The ex-dividend date of this dividend was Monday, February 4th. This represents a $1.68 annualized dividend and a yield of 3.75%. Metlife’s payout ratio is 31.17%.

In other Metlife news, EVP Steven J. Goulart sold 10,292 shares of the stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $44.40, for a total value of $456,964.80. Following the completion of the sale, the executive vice president now owns 93,214 shares of the company’s stock, valued at $4,138,701.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Carlos M. Gutierrez acquired 6,400 shares of the stock in a transaction on Monday, December 17th. The stock was purchased at an average cost of $39.04 per share, with a total value of $249,856.00. Following the transaction, the director now directly owns 4,668 shares of the company’s stock, valued at $182,238.72. The disclosure for this purchase can be found here. Company insiders own 0.34% of the company’s stock.

Several brokerages have recently weighed in on MET. Zacks Investment Research lowered shares of Metlife from a “buy” rating to a “hold” rating in a report on Monday, January 21st. ValuEngine upgraded shares of Metlife from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th. Bank of America upgraded shares of Metlife from a “neutral” rating to a “buy” rating and set a $44.06 price objective on the stock in a report on Wednesday, January 16th. Argus reiterated a “buy” rating on shares of Metlife in a report on Tuesday, February 12th. Finally, Wells Fargo & Co reiterated a “buy” rating on shares of Metlife in a report on Tuesday, January 8th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Metlife has a consensus rating of “Buy” and an average price target of $52.92.

WARNING: This article was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at https://www.thelincolnianonline.com/2019/03/15/kinneret-advisory-llc-purchases-new-position-in-metlife-inc-met.html.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Read More: Buy-Side Analysts

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply